Disposables was IceCure Medical’s largest product and service line in fiscal 2025, bringing in $2.05M of $3.38M (61%).
| Product and Service | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Disposables | $1.34M | $1.50M | $1.83M | $2.05M | |
| Systems | $1.00M | $1.45M | $1.36M | $1.33M | |
| Exclusive Distribution Agreement & Other Services | $747.00K | $274.00K | $100.00K | — | |
| Exclusive Distribution Agreement | — | — | — | — | |
| Total | $3.09M | $3.23M | $3.29M | $3.38M |
IceCure Medical brought in $3.38M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. IceCure Medical regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $3.29M. Disposables was the largest at $2.05M (60.8%), ahead of Systems at $1.33M (39.2%).
Compared with fiscal 2024, Disposables grew 12.3% to $2.05M, while Systems fell 2.7% to $1.33M.
IceCure Medical stopped reporting Exclusive Distribution Agreement & Other Services as a separate line after fiscal 2024, when it brought in $100.00K.
Other was IceCure Medical’s largest region in fiscal 2023, bringing in $1.51M of $3.23M (47%).
| Geography | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|
| Other | $1.22M | $1.19M | $1.51M |
| Japan | $1.38M | $1.13M | $480.00K |
| United States | $471.00K | $604.00K | $751.00K |
| Thailand | $964.00K | $30.00K | $14.00K |
| China | — | $104.00K | $440.00K |
| Israel | $108.00K | $30.00K | $30.00K |
| Total | $4.14M | $3.09M | $3.23M |
IceCure Medical brought in $3.23M from its six regions in fiscal 2023, the year ended December 31, 2023. That was up 4.7% from $3.09M in fiscal 2022. Other was the largest at $1.51M (46.9%), ahead of United States at $751.00K (23.3%) and Japan at $480.00K (14.9%). The other three regions brought in $484.00K combined.
Compared with fiscal 2022, China grew fastest, up 323.1% to $440.00K, while Japan fell the most, down 57.5% to $480.00K.
IceCure Medical began breaking out China in fiscal 2022, when it brought in $104.00K.
IceCure Medical (ICCM) reports its revenue by product and service and by geography. In fiscal 2025, Disposables was its largest product and service line, bringing in $2.05M (60.8% of the total), followed by Systems at $1.33M (39.2%).
Disposables was IceCure Medical's largest product and service line in fiscal 2025, bringing in $2.05M, or 60.8% of the $3.38M total across its two product and service lines.
Other was IceCure Medical's largest region in fiscal 2023, bringing in $1.51M, or 46.9% of the $3.23M total across its six regions.
Among IceCure Medical's regions that make up at least 2% of revenue, China grew fastest in fiscal 2023, up 323.1% from $104.00K to $440.00K.
Every figure comes from IceCure Medical's annual financial filings, as reported. Each line keeps the name IceCure Medical gives it, and years follow its fiscal calendar.
IceCure Medical's revenue by product and service goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.